Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Seltsam

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Medicine|December 20, 2017
Pathogen Inactivation of Cellular Blood Products-An Additional Safety Layer in Transfusion MedicineAxel Seltsam
Current Opinion in Hematology|September 5, 2009
Recombinant blood group proteins for use in antibody screening and identification testsAxel Seltsam, Rainer Blasczyk
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 30, 2010
Sequence-Based Typing of Human Blood GroupsAxel Seltsam, Andrea Doescher
Transfusion|September 27, 2005
Missense mutations outside the catalytic domain of the ABO glycosyltransferase can cause weak blood group A and B phenotypesAxel Seltsam, Rainer Blasczyk
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 23, 2011
UVC Irradiation for Pathogen Reduction of Platelet Concentrates and PlasmaAxel Seltsam, Thomas H Müller
The Journal of Allergy and Clinical Immunology|January 17, 2013
Updated hemovigilance data do not show an increased risk of allergic reactions to methylene blue-treated plasmaAxel Seltsam, Thomas H Mueller
British Journal of Haematology|May 29, 2013
Update on the use of pathogen-reduced human plasma and platelet concentratesAxel Seltsam, Thomas H Müller
Journal of Molecular Medicine (Berlin, Germany)|November 13, 2008
Permanent silencing of NKG2A expression for cell-based therapeuticsConstança Figueiredo, Axel Seltsam, Rainer Blasczyk
Transfusion|August 30, 2007
Prokaryotic versus eukaryotic recombinant Lutheran blood group protein for antibody identificationAxel Seltsam, Daniela Grüger, Rainer Blasczyk
Journal of Molecular Medicine (Berlin, Germany)|March 8, 2006
Class-, gene-, and group-specific HLA silencing by lentiviral shRNA deliveryConstança Figueiredo, Axel Seltsam, Rainer Blasczyk
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Medicine|December 20, 2017
Pathogen Inactivation of Cellular Blood Products-An Additional Safety Layer in Transfusion MedicineAxel Seltsam
Current Opinion in Hematology|September 5, 2009
Recombinant blood group proteins for use in antibody screening and identification testsAxel Seltsam, Rainer Blasczyk
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 30, 2010
Sequence-Based Typing of Human Blood GroupsAxel Seltsam, Andrea Doescher
Transfusion|September 27, 2005
Missense mutations outside the catalytic domain of the ABO glycosyltransferase can cause weak blood group A and B phenotypesAxel Seltsam, Rainer Blasczyk
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 23, 2011
UVC Irradiation for Pathogen Reduction of Platelet Concentrates and PlasmaAxel Seltsam, Thomas H Müller
The Journal of Allergy and Clinical Immunology|January 17, 2013
Updated hemovigilance data do not show an increased risk of allergic reactions to methylene blue-treated plasmaAxel Seltsam, Thomas H Mueller
British Journal of Haematology|May 29, 2013
Update on the use of pathogen-reduced human plasma and platelet concentratesAxel Seltsam, Thomas H Müller
Journal of Molecular Medicine (Berlin, Germany)|November 13, 2008
Permanent silencing of NKG2A expression for cell-based therapeuticsConstança Figueiredo, Axel Seltsam, Rainer Blasczyk
Transfusion|August 30, 2007
Prokaryotic versus eukaryotic recombinant Lutheran blood group protein for antibody identificationAxel Seltsam, Daniela Grüger, Rainer Blasczyk
Journal of Molecular Medicine (Berlin, Germany)|March 8, 2006
Class-, gene-, and group-specific HLA silencing by lentiviral shRNA deliveryConstança Figueiredo, Axel Seltsam, Rainer Blasczyk
Pageof 8